Holen Sie sich die Stockscreener-App
0.2408
5.46%
-0.0139
Handel nachbörslich:
.25
0.0092
+3.82%
AEON Biopharma Inc. Aktie (AEON) Neueste Nachrichten
AEON Biopharma to Participate in Lake Street Capital Markets’ 10th Annual Best Ideas Growth (BIG10) Conference - manilatimes.net
AEON Biopharma to Host Investor Meetings at Lake Street Capital Markets’ 10th Annual BIG10 Conference - Quiver Quantitative
AEON Biopharma names Paul Lee as acting chief regulatory officer By Investing.com - Investing.com Nigeria
AEON Biopharma Designates Former FDA Neuroscience Leader Paul Lee, M.D., Ph.D. as Acting Chief Regulatory Officer - manilatimes.net
Aeon Biopharma director Timothy Lynch buys $243,455 in stock - Investing.com
Timothy Lynch (NASDAQ: AEON) owns 13% and holds blocked warrants - Stock Titan
AEON Reports New Data on Botox Biosimilar - Orange County Business Journal
Lake Street Maintains AEON Biopharma(AEON.US) With Buy Rating, Maintains Target Price $1 - Moomoo
AEON Flat on BOTOX Developments - Baystreet.ca
META_TITLE_QUOTE - Yahoo Finance
AEON Reports Expanded Structural Data Supporting Molecular Similarity of ABP-450 to BOTOX® - The Manila Times
AEON Biopharma (AEON) Steadies at $0.28 as Key Support HoldsVolume Gap - vinanet.vn
H.C. Wainwright cuts Aeon Biopharma stock price target on dilution - Investing.com
H.C. Wainwright cuts Aeon Biopharma stock price target on dilution By Investing.com - Investing.com UK
AEON Biopharma (AEON) Holds Above $0.27 Support as Shares Edge Up 1.66%Extension Target - vinanet.vn
AEON Q4 2025 Earnings: Wider-than-Expected Loss of -$0.42 per Share as Revenue Remains Absent - vinanet.vn
H.C. Wainwright Maintains AEON Biopharma(AEON.US) With Buy Rating, Cuts Target Price to $1.2 - Moomoo
AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update - manilatimes.net
AEON Biopharma Q2 EPS $(0.02) beats $(0.12) estimate - scanx.trade
AEON Biopharma Reports Q2 Results, Advances ABP-450 Program - TipRanks
AEON Biopharma Q2 net loss narrows on warrant gain; cash runway extended - TradingView
AEON Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
AEON BIOPHARMA INC Q2 EBIT USD -5.919 MILLION - Moomoo
Aeon Biopharma Inc (AEON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AEON Biopharma Regains Compliance with NYSE American Continued Listing Standards - The Manila Times
Aeon Biopharma Inc (AEON) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
AEON Biopharma Regains NYSE American Listing Compliance - TipRanks
AEON Biopharma Regains NYSE American Compliance After Completing Public Offering - Quiver Quantitative
AEON Biopharma (NYSE American: AEON) lifts .BC indicator after $13.6M equity raise - Stock Titan
AEON Q4 2025 Earnings: Wider Loss of -$0.42 Per Share Overshadowed by 14.81% Stock SurgeHealthcare Earnings Report - vinanet.vn
AEON Q4 2025 Earnings: Deep EPS Miss Overshadowed by 14.81% Share RallyPeak Earnings Alert - vinanet.vn
AEON Biopharma, Inc. Revenue Breakdown – AMEX:AEON - tradingview.com
Aeon Biopharma Inc (AEON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
AEON|Aeon Biopharma Inc|Price:0.257|Chg%:+0.006 - TradingKey
Aeon Biopharma Inc (AEON) Valuation: PE, PB & Fair Value Analysis - TradingKey
Aeon Biopharma Inc (AEON) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aeon Biopharma Inc (AEON) Income Statement - TradingKey
Aeon Biopharma Inc (AEON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bitget Launchpool adds AEON (AEON) with 1.1M in Token Rewards - GlobeNewswire Inc.
Aeon Biopharma Inc (AEON) Balance Sheet - TradingKey
Aeon Biopharma Inc (AEON) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aeon Biopharma Inc (AEON) Cash Flow - TradingKey
AEON|Aeon Biopharma Inc|Price:0.241|Chg%:-0.014 - TradingKey
AEON Biopharma, Inc. Revenue Breakdown – BOATS:AEON - TradingView
Aeon Biopharma Inc (AEON) Institutional Confidence - TradingKey
Aeon Biopharma Inc (AEON) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
AEON|Aeon Biopharma Inc|Price:0.295|Chg%:+0.005 - TradingKey
AEON Biopharma boosts liquidity with additional share sale - The Globe and Mail
AEON Biopharma says underwriters fully exercise milestone warrant over-allotment option for 6,403,290 shares - Bitget
Stonepine Capital group discloses 9.9% AEON Biopharma (AEON) ownership via stock and warrants - Stock Titan
AEON Q4 2025 Earnings: Significant EPS Miss as Biotech Continues Development PhaseProfit Growth Outlook - vinanet.vn
AEON Biopharma Inc. (AEON) Hovers Near Support as Bearish Pressure PersistsMutual Fund Flow - dars.gov.et
NFA- today's 8K - Moomoo
AEON Biopharma (NYSE American: AEON) prices $13.75M stock and milestone warrant sale - Stock Titan
AEON Biopharma (NYSE American: AEON) sells stock and milestone-tied warrants - Stock Titan
AEON BiopharmaOffering Includes 42.69 Mln - Moomoo
AEON Biopharma Announces Pricing of Upsized $13.75 Million Public Offering with Accompanying Milestone Warrants Providing Potential for Additional Future Funding - The Manila Times
AEON Biopharma Could Raise $29.6M More Through Warrants - Stock Titan
AEON Biopharma, Inc. SEC Filing (Jul 14, 2026) - Stock Titan
AEON Biopharma (AEON) Slides 10% Towards Key Support as Selling Pressure IntensifiesSwing Entry Signals - vinanet.vn
AEON Biopharma (NASDAQ: AEON) revises S-1 filing fee table for milestone warrants - Stock Titan
AEON Biopharma Offering 17.5M Shrs or Pre-Funded Warrants Along With Two-Year and Five-Year Milestone Warrants - Moomoo
0.86%
0.31%
Kapitalisierung:
|
Volumen (24h):